As of 2026-10-06, the Relative Valuation of Arcutis Biotherapeutics Inc (ARQT) is 8.67 USD. This relative valuation is based on P/E multiples. With the latest stock price at 25.15 USD, the upside of Arcutis Biotherapeutics Inc based on Relative Valuation is -65.5%.
The range of the Relative Valuation is 6.61 - 11.97 USD.
| Range | Selected | |
| Trailing P/E multiples | 29.0x - 40.9x | 35.0x |
| Forward P/E multiples | 29.7x - 52.5x | 41.1x |
| Fair Price | 6.61 - 11.97 | 8.67 |
| Upside | -73.7% - -52.4% | -65.5% |
| Date | P/E |
| 2026-10-02 | 110.35 |
| 2026-10-01 | 110.92 |
| 2026-09-30 | 115.92 |
| 2026-09-29 | 117.32 |
| 2026-09-28 | 119.87 |
| 2026-09-25 | 118.07 |
| 2026-09-24 | 115.22 |
| 2026-09-23 | 115.70 |
| 2026-09-22 | 121.84 |
| 2026-09-21 | 113.86 |
| 2026-09-18 | 111.31 |
| 2026-09-17 | 116.05 |
| 2026-09-16 | 114.65 |
| 2026-09-15 | 103.11 |
| 2026-09-14 | 106.44 |
| 2026-09-11 | 104.76 |
| 2026-09-10 | 102.54 |
| 2026-09-09 | 104.56 |
| 2026-09-08 | 106.97 |
| 2026-09-04 | 104.82 |
| 2026-09-03 | 103.77 |
| 2026-09-02 | 104.60 |
| 2026-09-01 | 104.16 |
| 2026-08-31 | 105.13 |
| 2026-08-28 | 104.30 |
| 2026-08-27 | 109.08 |
| 2026-08-26 | 110.26 |
| 2026-08-25 | 109.03 |
| 2026-08-24 | 108.68 |
| 2026-08-21 | 110.00 |
| 2026-08-20 | 111.18 |
| 2026-08-19 | 116.05 |
| 2026-08-18 | 116.40 |
| 2026-08-17 | 112.32 |
| 2026-08-14 | 114.87 |
| 2026-08-13 | 113.29 |
| 2026-08-12 | 115.26 |
| 2026-08-11 | 115.04 |
| 2026-08-10 | 113.68 |
| 2026-08-07 | 110.92 |
| 2026-08-06 | 115.92 |
| 2026-08-05 | 118.86 |
| 2026-08-04 | 114.16 |
| 2026-08-03 | 113.77 |
| 2026-07-31 | 117.80 |
| 2026-07-30 | 122.76 |
| 2026-07-29 | 122.19 |
| 2026-07-28 | 124.65 |
| 2026-07-27 | 122.10 |
| 2026-07-24 | 119.95 |